Unresectable Merkel Cell Carcinoma
5 clinical trials · Condition
◉ Watch Unresectable Merkel Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer (NCT05896839) | National Cancer Institute (NCI) | 2024-07-24 |
| Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial (NCT05947500) | National Cancer Institute (NCI) | 2024-05-21 |
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381) | Mayo Clinic | 2022-03-31 |
| Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers (NCT03816332) | National Cancer Institute (NCI) | 2019-11-08 |
Track Unresectable Merkel Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.